Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A novel DNA vaccine-targeting macrophage migration inhibitory factor improves the survival of mice with sepsis

Gene Therapy volume 15, pages 1513–1522 (2008)Cite this article

Abstract

Sepsis is a common and frequently fatal condition and there is an urgent need for new therapies that will further reduce sepsis-induced mortality. Macrophage migration inhibitory (MIF) factor is important in the regulation of innate and adaptive immunity and is believed to play a key regulatory role in sepsis and autoimmune disease. As MIF deficiency or immunoneutralization protects mice or rats from fatal endotoxic shock or other inflammatory diseases, we examined whether DNA vaccination against this molecule would also be protective. DNA vaccines can stimulate both humoral and cellular immunity simultaneously and have been shown to be effective against a variety of pathogens or cytokine-driven pathologies. Mice were immunized with a MIF/tetanus toxin (TTX) DNA vaccine and sepsis was then induced by lipopolysaccharide or cecal ligation and puncture. The MIF/TTX DNA-vaccinated mice were protected from the lethal effect of sepsis compared with control-vaccinated mice in both models. Compared with the control-vaccinated mice, the MIF/TTX DNA-vaccinated mice also showed significantly lower serum tumor necrosis factor (TNF)-α protein levels and reduced mRNA expression of TNF-α, interleukin (IL)-1β, IL-6, macrophage inflammatory protein-2 and Toll-like receptor-4 in the lungs. Thus, the MIF/TTX DNA vaccine may be useful for the prophylaxis of septic shock.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Toh ML, Aeberli D, Lacey D, Yang Y, Santos LL, Clarkson M et al. Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol 2006; 177: 4818–4825.

    Article  CAS  Google Scholar 

  2. Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J . Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 2002; 4: 449–460.

    Article  CAS  Google Scholar 

  3. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164–170.

    Article  CAS  Google Scholar 

  4. Lai KN, Leung JC, Metz CN, Lai FM, Bucala R, Lan HY . Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol 2003; 199: 496–508.

    Article  CAS  Google Scholar 

  5. Roger T, David J, Glauser MP, Calandra T . MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001; 414: 920–924.

    Article  CAS  Google Scholar 

  6. Clark M . Antibody humanization: a case of the ‘Emperor's new clothes’? Immunol Today 2000; 21: 397–402.

    Article  CAS  Google Scholar 

  7. Onodera S, Ohshima S, Tohyama H, Yasuda K, Nishihira J, Iwakura Y et al. A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis. Arthritis Rheum 2007; 56: 521–530.

    Article  CAS  Google Scholar 

  8. Buras JA, Holzmann B, Sitkovsky M . Animal models of sepsis: setting the stage. Nat Rev Drug Discov 2005; 4: 854–865.

    Article  CAS  Google Scholar 

  9. Fink MP, Heard SO . Laboratory models of sepsis and septic shock. J Surg Res 1990; 49: 186–196.

    Article  CAS  Google Scholar 

  10. Riedemann NC, Neff TA, Guo RF, Bernacki KD, Laudes IJ, Sarma JV et al. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol 2003; 170: 503–507.

    Article  CAS  Google Scholar 

  11. Dinarello CA, Thompson RC . Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12: 404–410.

    Article  CAS  Google Scholar 

  12. Heinzel FP . The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 1990; 145: 2920–2924.

    CAS  PubMed  Google Scholar 

  13. Dinapoli MR, Calderon CL, Lopez DM . The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J Exp Med 1996; 183: 1323–1329.

    Article  CAS  Google Scholar 

  14. Riedemann NC, Guo RF, Ward PA . Novel strategies for the treatment of sepsis. Nat Med 2003; 9: 517–524.

    Article  CAS  Google Scholar 

  15. Hotchkiss RS, Karl IE . The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138–150.

    Article  CAS  Google Scholar 

  16. Baugh JA, Bucala R . Macrophage migration inhibitory factor. Crit Care Med 2002; 30: S27–S35.

    Article  CAS  Google Scholar 

  17. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999; 189: 341–346.

    Article  CAS  Google Scholar 

  18. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365: 756–759.

    Article  CAS  Google Scholar 

  19. Honma N, Koseki H, Akasaka T, Nakayama T, Taniguchi M, Serizawa I et al. Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 2000; 100: 84–90.

    Article  CAS  Google Scholar 

  20. Calandra T . Macrophage migration inhibitory factor and host innate immune responses to microbes. Scand J Infect Dis 2003; 35: 573–576.

    Article  CAS  Google Scholar 

  21. Echtenacher B, Freudenberg MA, Jack RS, Mannel DN . Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun 2001; 69: 7271–7276.

    Article  CAS  Google Scholar 

  22. Riedemann NC, Guo RF, Ward PA . The enigma of sepsis. J Clin Invest 2003; 112: 460–467.

    Article  CAS  Google Scholar 

  23. Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, Ochani M et al. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem 2005; 280: 36541–36544.

    Article  CAS  Google Scholar 

  24. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3: 320–323.

    Article  CAS  Google Scholar 

  25. Chagnon F, Metz CN, Bucala R, Lesur O . Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ Res 2005; 96: 1095–1102.

    Article  CAS  Google Scholar 

  26. Muzio M, Bosisio D, Polentarutti N, D’amico G, Stoppacciaro A, Mancinelli R et al. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000; 164: 5998–6004.

    Article  CAS  Google Scholar 

  27. Lowe DB, Shearer MH, Kennedy RC . DNA vaccines: successes and limitations in cancer and infectious disease. J Cell Biochem 2006; 98: 235–242.

    Article  CAS  Google Scholar 

  28. Donnelly JJ, Wahren B, Liu MA . DNA vaccines: progress and challenges. J Immunol 2005; 175: 633–639.

    Article  CAS  Google Scholar 

  29. Donnelly JJ, Ulmer JB, Liu MA . DNA vaccines. Dev Biol Stand 1998; 95: 43–53.

    CAS  PubMed  Google Scholar 

  30. Jouvenne P, Fossiez F, Banchereau J, Miossec P . High levels of neutralizing autoantibodies against IL-1 alpha are associated with a better prognosis in chronic polyarthritis: a follow-up study. Scand J Immunol 1997; 46: 413–418.

    Article  CAS  Google Scholar 

  31. Dalum I, Butler DM, Jensen MR, Hindersson P, Steinaa L, Waterston AM et al. Therapeutic antibodies elicited by immunization against TNF-alpha. Nat Biotechnol 1999; 17: 666–669.

    Article  CAS  Google Scholar 

  32. Zagury D, Le Buanec H, Bizzini B, Burny A, Lewis G, Gallo RC . Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases. Cytokine Growth Factor Rev 2003; 14: 123–137.

    Article  CAS  Google Scholar 

  33. Abe R, Shimizu T, Ohkawara A, Nishihira J . Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. Biochim Biophys Acta 2000; 1500: 1–9.

    Article  CAS  Google Scholar 

  34. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248–251.

    Article  CAS  Google Scholar 

  35. Nemeth ZH, Csoka B, Wilmanski J, Xu D, Lu Q, Ledent C et al. Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. J Immunol 2006; 176: 5616–5626.

    Article  CAS  Google Scholar 

  36. Ward PA . The dark side of C5a in sepsis. Nat Rev Immunol 2004; 4: 133–142.

    Article  CAS  Google Scholar 

  37. Aihara H, Miyazaki J . Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867–870.

    Article  CAS  Google Scholar 

  38. Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K et al. Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 2000; 5: 397–403.

    CAS  PubMed  Google Scholar 

  39. Overhaus M, Moore BA, Barbato JE, Behrendt FF, Doering JG, Bauer AJ . Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am J Physiol Gastrointest Liver Physiol 2006; 290: G695–G703.

    Article  CAS  Google Scholar 

  40. Wong ML, Medrano JF . Real-time PCR for mRNA quantitation. Biotechniques 2005; 39: 75–85.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by a Grant-in-Aid from the Ministry of Science and Education of Japan (60301884).

Author information

Authors and Affiliations

  1. Department of Sports Medicine and Joint Reconstruction Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    S Tohyama, S Onodera, H Tohyama & K Yasuda

  2. Department of Medical Information, Hokkaido Information University, Ebetsu, Japan

    J Nishihira & Y Koyama

  3. Sapporo Immuno Diagnostic Laboratory, Sapporo, Japan

    Y Mizue

  4. Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    A Hamasaka & R Abe

Authors
  1. S Tohyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Onodera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Tohyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Yasuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Nishihira
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y Mizue
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Hamasaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Y Koyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Onodera.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tohyama, S., Onodera, S., Tohyama, H. et al. A novel DNA vaccine-targeting macrophage migration inhibitory factor improves the survival of mice with sepsis. Gene Ther 15, 1513–1522 (2008). https://doi.org/10.1038/gt.2008.112

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2008.112

Keywords

This article is cited by

Search

Advanced search

Quick links